Precision Medicine: The Role of Pharmacists and Reimbursement Challenges

With these words in 2015, President Barack Obama announced a $215 million commitment to research and development of treatment and prevention strategies tailored to a patient’s unique characteristics, including his or her genome sequence. This Precision Medicine Initiative put impetus behind the concept of personalized medications, foreseen as powerful tools for achieving drug efficacy while avoiding adverse drug events and reducing healthcare costs through prevention of drug-related hospitalizations.

While the promise of precision medicine is monumental, delivery is not without stumbling blocks and a great deal of change and effort will be required by all stakeholders. In this paper, we focus on one key participant – the pharmacist – with emphasis on some of the challenges in the reimbursement process..

Download Whitepaper

About Clinical Solutions

Elsevier empowers healthcare providers and educates patients, driving the delivery of high quality, economically sound care through world-class clinical content integrated within clinical workflow and EHR systems.

Learn more